Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 Years experience in Chile

Lupus

Volumn 14, Issue 11, 2005, Pages 918-923

  González, Benito ^a   Hernandez P ^a   Olguin H ^a   Miranda, M ^b   Lira, L ^c   Toso, M ^d   Quezada, A ^e   Norambuena, X ^e   Talesnik, E ^f   Mendez C ^g   Navarrete, C ^h  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

^b San Juan de Dios Hospital   (Philippines)

^c Carabineros Hospital

^d Militar Hospital   (Spain)

^e Hospital Exequiel Gonzalez Cortes   (Chile)

^f Pediatric Department

^g HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^h HOSPITAL ROBERTO DEL RÍO   (Chile)

Author keywords

Childhood; Chile; Survival; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; STEROID;

ADOLESCENT; ARTICLE; CAUSE OF DEATH; CHILD; CHILE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; LIFE EXPECTANCY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 28444452949     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu2183xx     Document Type: Article

References (29)

1. Zetterstrom R, Bergland G. Systemic lupus erythematosus in childhood: a clinical study. Paediatrica 1956; 5: 189-204.
2. Liang MH, Partridge AJ, Daltroy LH et al. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum 1991; 34: 1187-1196.
3. Pistiner M, Wallace DJ, Nessim S et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 1: 55-64.
4. Samanta A, Feehally J, Roy S et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
5. Bellomio V, Spindler A, Lucero E et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 2000; 9: 377-379.
6. González B, Elgueta S, Talesnik E et al. Lupus eritematoso diseminado en la infancia. Estudio clínico y de sobrevida en 31 casos. Rev Chil Pediatr 1984; 55: 238-241.
7. Ling MH, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy. Arch Gen Psych 1981; 38: 371-374.
8. Tan EM, Cohen AJ, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-459.
10. Mathews DE, Farewell VT. Estadística Médica. Aplicación e interpretación 2nd edn. Barcelona, Spain: Salvat Editores S.A., 1990.
11. Miranda M, Talesnik E, Gonzalez B et al. Enfermedades reumáticas y del tejido conectivo en niños de Santiago, Chile, Rev Chil Pediatr 1996; 67: 200-205.
12. Gonzalez B, King A. Estudio del lupus eritematoso sistémico en la infancia. Reumatología 1992; 8: 77-80.
13. Meislin AG, Rothfield N. Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 1968; 42: 37-49.
14. Abeles M, Urman J, Weistein A, Lowentein M, Rothifields N. Systemic lupus erythematosus in the younger patients: survival studies. J Rheumatol 1980; 7: 515-522.
15. Caerio F, Michielson R, Bernstein G, Hughes V, Ansell B. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981; 40: 325-331.
16. Gourley MF, Austin HA, Scott D et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 1996; 125: 549-557.
17. Lehman TJ, Sherry DD, Wagner L et al. Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr 1989; 114: 1055-1060.
18. Niaudet P. Treatment of lupus nephritis in children. Pediatr Nephrol 2000; 14: 158-166.
19. Massardo L, Martinez ME, Jacobelly S, Villarroel L, Rosenberg H, Rivero S. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24: 1-11.
20. Huicochea ZL, Berron R, Ortega JA, Onuma E. Survival up to 5 and 10 years of Mexican pediatric patients with systemic lupus erythematosus. Overhaul of 23 years experience. Allergol Immunopathol (Madr) 1996; 24: 36-38.
21. Lehman T, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000; 136: 243-247.
22. Lacks S, White P. Morbibity associated with childhood systemic lupus erythematosus. J Rheumatol 1990; 17: 941-945.
23. Iliopolus AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996; 25: 318-322.
24. Ehrke MJ, Mihich E, Berd D, Mastragelo MJ. Effects of anticancer drugs on the immune system in humans. Semin Oncol 1989; 6: 23-27.
25. Padula SJ, Clark RB, Kom JH. Cell-mediated immunity in rheumatic disease. Hum Pathol 1986; 17: 254-258.
26. Gladman DD, Ginzler E, Goldsmith CH et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
27. Brunner HI, Silverman ED, To T, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Artrhritis Rheum 2002; 46: 436-444.
28. Petri M, Genovese M, Eugle E, Hochberg MC. Definition, incidente and clinical description of flare in systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum 1992; 35: 630.
29. Bombardier C, Gladman DD, Urowit M et al. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630.